Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2014
12/10/2014CN101868534B 用于鉴定、扩增和去除成体干细胞和癌干细胞的方法 For the identification, amplification and removal of adult stem cells and cancer stem cells
12/10/2014CN101861164B 朊病毒蛋白相关疾病的治疗 Treatment of a disease associated prion protein
12/10/2014CN101827936B Cdh3肽以及含有cdh3肽的药剂 Cdh3 peptides and peptide drug containing cdh3
12/10/2014CN101678078B Sparc及其使用方法 Sparc and methods of use
12/09/2014US8909483 Direct or indirect diagnostic test for helminth infection
12/09/2014US8907163 Transgenic plants expressing galactosyltransferase and sialyl transferase
12/09/2014US8907078 Antisense oligonucleotides (ODN) against SMAD7 and uses thereof in medical field
12/09/2014US8907071 Toxin peptide therapeutic agents
12/09/2014US8907068 Anti-IL-20 antibodies and binding partners and methods of using in inflammation
12/09/2014US8907066 Antibody fusion proteins with a modified FcRn binding site
12/09/2014US8907064 Modified human four helical bundle polypeptides and their uses
12/09/2014US8907060 Mutated Pseudomonas exotoxins with reduced antigenicity
12/09/2014US8907057 Peptides that target dorsal root ganglion neurons
12/09/2014US8907055 Mutant sox proteins and methods of inducing pluripotency
12/09/2014US8907053 Immunosuppression modulating compounds
12/09/2014US8906951 Use of NK-1 receptor antagonists in pruritus
12/09/2014US8906929 Inhibitors of human immunodeficiency virus replication
12/09/2014US8906926 Substituted diketopiperazine analogs for use as drug delivery agents
12/09/2014US8906901 Administration of dipeptidyl peptidase inhibitors
12/09/2014US8906897 Antimicrobial agents based on hemin derivatives
12/09/2014US8906866 Antibiotic compositions for the treatment of gram negative infections
12/09/2014US8906865 Treatment of inflammation and/or endotoxic shock
12/09/2014US8906864 Binding domains of proteins of the repulsive guidance molecule (RGM) protein family and functional fragments thereof, and their use
12/09/2014US8906863 Proteolysis-resistant capsid of chimeric hepatitis E virus as an oral delivery vector
12/09/2014US8906862 Multiple antigen delivery system using hepatitis E virus-like particle
12/09/2014US8906861 Pharmaceutical compositions comprising cyclosporins
12/09/2014US8906860 Methods and compositions inhibiting tumor cell proliferation
12/09/2014US8906859 Uses of kappa opioid synthetic peptide amides
12/09/2014US8906858 Method for the prophylactic or therapeutic treatment of glucocorticoid-induced osteoporosis
12/09/2014US8906857 Methods for the diagnosis and treatment of critically ill patients with endothelin, endothelin agonists and adrenomedullin antagonists
12/09/2014US8906856 Single component fibrin hemostat
12/09/2014US8906855 Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
12/09/2014US8906854 Methods for treating metabolic disorders using FGF
12/09/2014US8906853 [N-Me-4-hydroxyleucine]-9-cyclosporin analogues for treatment and prevention of hepatitis C infection
12/09/2014US8906852 Inhibitors of protein tyrosine kinase activity
12/09/2014US8906851 Method for treating diabetes
12/09/2014US8906850 Crystalline insulin-conjugates
12/09/2014US8906849 Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
12/09/2014US8906848 Aureobasidin derivatives and methods of synthesis
12/09/2014US8906846 Method of treating inflammatory bowel disease by administering a clip-inducing agent
12/09/2014US8906845 Peptide compounds to regulate the complement system
12/09/2014US8906844 Immunomodulatory peptides
12/09/2014US8906681 Reliable stabilization of N-linked polypeptide native states with enhanced aromatic sequons located in polypeptide tight turns
12/09/2014US8906679 Composite for thermo-sensitive cell-tissue transplanted scaffold and use thereof
12/09/2014US8906676 Modified human four helical bundle polypeptides and their uses
12/09/2014US8906675 Adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
12/09/2014US8906667 Increasing NADPH-dependent products
12/09/2014US8906662 Compositions and methods for treating inflammatory bowel disease and airway inflammation
12/09/2014US8906661 ADAMTS-13 mutant
12/09/2014US8906648 Recombinant production of vascular endothelial growth factor
12/09/2014US8906640 Methods of measuring protein and/or fat digestibility and uses thereof
12/09/2014US8906637 Methods for detecting targets
12/09/2014US8906444 Diazonium salt modification of silk polymer
12/09/2014US8906425 Stimulation of the synthesis of the activity of an isoform of lysyl oxidase-like LOXL for stimulating the formation of elastic fibers
12/09/2014US8906424 Licorice polyphenol preparation
12/09/2014US8906390 Synthetic lipid rafts and methods of use
12/09/2014US8906384 Antiviral activity of bovine type III interferon against foot-and-mouth disease virus
12/09/2014US8906383 T cell receptor having binding affinity for a peptide-MHC complex and uses thereof
12/09/2014US8906380 Fungal immunostimulatory compositions
12/09/2014US8906379 Targeting of glycoprotein therapeutics
12/09/2014US8906378 Combination therapy with anti-CD74 antibodies provides enhanced toxicity to malignancies, autoimmune disease and other diseases
12/09/2014US8906377 Stably tethered structures of defined compositions with multiple functions or binding specificities
12/09/2014US8906366 Methods for preparing factor X, activated factor X, inactivated factor X and inactivated factor Xa, and pharmaceutical compositions comprising same
12/09/2014US8906365 Antimicrobial agents
12/09/2014US8906364 Antimicrobial compositions and uses thereof
12/09/2014US8906363 Fusion proteins for the treatment of CNS
12/09/2014US8906360 Light-activated cation channel and uses thereof
12/09/2014US8906356 Mutant interleukin-2 (IL-2) polypeptides
12/09/2014US8906355 Synthetic stereoisomer peptides in the retro-inverso and inverso configuration, and with cyclic and linear structure, their polymer conjugates, their encapsulation in polymer particles, and uses thereof
12/09/2014US8905979 Method of administration of a pulmonary surfactant
12/09/2014US8905913 Method and composition for synchronizing time of insemination
12/05/2014DE202012013134U1 Pharmazeutische Aerosolformulierung von Protease-Inhibitoren und deren Zubereitung A pharmaceutical aerosol formulation of protease inhibitors and their preparation
12/04/2014US20140357855 Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure
12/04/2014US20140357846 Thyroid stimulating hormone compositions
12/04/2014US20140357844 Antibodies specific for trop-2 and their uses
12/04/2014US20140357843 Immunoglobulin fc variants
12/04/2014US20140357842 Yersinia outer protein m (yopm) in the treatment of psoriasis
12/04/2014US20140357698 Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure
12/04/2014US20140357586 Solid Carriers for Improved Delivery of Active Ingredients in Pharmaceutical Compositions
12/04/2014US20140357576 Methods for enhancement of muscle protein synthesis
12/04/2014US20140357574 Novel sustained release polymer
12/04/2014US20140357572 Neurotrophic peptides for the treatment of tauopathies
12/04/2014US20140357571 Glutamine enriched nutritional composition for preterm infants
12/04/2014US20140357570 Compositions comprising necrosis inhibitors, such as necrostatins, alone or in combination, for promoting axon regeneration and nerve function, thereby treating cns disorders
12/04/2014US20140357568 Method of Increasing Muscle Mass and Strength and Compositions Therefor
12/04/2014US20140357566 Identification and molecular characterisation of proteins, expressed in the ixodes ricinus salivary glands
12/04/2014US20140357563 Compositions and Methods for the Generation of Activated Protein C and Methods of Use Thereof
12/04/2014US20140357562 Beta-Arrestin Effectors And Compositions And Methods Of Use Thereof
12/04/2014US20140357561 Natriuretic polypeptide delivery systems
12/04/2014US20140357560 Pth-containing therapeutic/prophylactic agent for osteoporosis, characterized in that pth is administered once a week in a unit dose of 100 to 200 units
12/04/2014US20140357557 Cyclodextrin-based polymers for therapeutic delivery
12/04/2014US20140357556 Novel Target for Diagnosis and Treatment of Diabetes and Cardiovascular Diseases
12/04/2014US20140357554 Magnesium Compositions for Modulating the Pharmacokinetics and Injection Site Pain of Insulin
12/04/2014US20140357553 Nutritional composition for wound healing
12/04/2014US20140357551 Organic compounds and their uses
12/04/2014US20140357550 Pharmaceutical Composition for Treatment of Acute Toxic Conditions
12/04/2014US20140357548 Methods for preventing or treating certain disorders by inhibiting binding of il-4 and/or il-13 to their respective receptors
12/04/2014US20140356957 Biological Pacemaker
12/04/2014US20140356814 Dental implant having enhanced early stability and method for manufacturing same
12/04/2014US20140356442 Pharmaceutical compositions of triptorelin microspheres
1 ... 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 ... 3163